Literature DB >> 10811011

Differential chemokine receptor expression and function in human monocyte subpopulations.

C Weber1, K U Belge, P von Hundelshausen, G Draude, B Steppich, M Mack, M Frankenberger, K S Weber, H W Ziegler-Heitbrock.   

Abstract

The subset of human blood monocytes expressing low levels of CD14 and high levels of CD16 (CD14+CD16+) exhibits features resembling mature tissue macrophages and can be expanded in inflammatory conditions. We analyzed expression of CC chemokine receptors (CCR) in CD14+CD16+ versus CD14++ monocytes, which may be crucial for specific trafficking. Multicolor flow cytometric analysis of whole peripheral blood revealed that, as opposed to CD14++ monocytes, the CD14+CD16+ subset lacked surface expression of monocyte chemotactic protein-1 (MCP-1) receptor CCR2, however, it showed significantly higher surface expression of the macrophage inflammatory protein 1alpha (MIP-1alpha)/RANTES receptor CCR5. This was paralleled by differences in mRNA expression in the subsets, as shown by reverse transcriptase-polymerase chain reaction using sorted cells. In comparison to CD14++ monocytes, CD14+CD16+ cells expressed lower CCR2 but higher CCR5 transcript levels, whereas CCR1 levels were equivalent. Flow cytometric analysis of isolated human monocytes recovered after transendothelial chemotaxis assays revealed that the percentage of CD14+CD16+ cells was dramatically reduced in the fraction migrating toward MCP-1 compared with the fraction that did not migrate or the input, showing that polarized CCR2 expression was accompanied by a differential chemotactic responsiveness. Moreover, CD11b surface expression was preferentially up-regulated by MCP-1 in CD14++ cells but by MIP-1alpha in CD14+CD16+ monocytes, confirming the functional relevance of distinct CCR expression. The characteristics of CD14+CD16+ cells may reflect preactivation by cytokines and determine their predilective localization during specific inflammatory conditions or susceptibility to infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811011     DOI: 10.1002/jlb.67.5.699

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  111 in total

1.  Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease.

Authors:  S Koch; T Kucharzik; J Heidemann; A Nusrat; A Luegering
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Authors:  Suad Kapetanovic; Erin Leister; Sharon Nichols; Tracie Miller; Katherine Tassiopoulos; Rohan Hazra; Harris A Gelbard; Kathleen M Malee; Betsy Kammerer; Armando J Mendez; Paige L Williams
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 3.  The multiple roles of monocyte subsets in steady state and inflammation.

Authors:  Clinton S Robbins; Filip K Swirski
Journal:  Cell Mol Life Sci       Date:  2010-05-01       Impact factor: 9.261

4.  Expansion of CD14(+)CD16(+) monocytes is related to acute leukemia.

Authors:  Xin-Quan Jiang; Lei Zhang; Hong-Ai Liu; Ning Yuan; Pei-Qiang Hou; Rong-Qiang Zhang; Tuo Wu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 5.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 6.  Nonclassical patrolling monocyte function in the vasculature.

Authors:  Graham Thomas; Robert Tacke; Catherine C Hedrick; Richard N Hanna
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

7.  Expression of GM1, a marker of lipid rafts, defines two subsets of human monocytes with differential endocytic capacity and lipopolysaccharide responsiveness.

Authors:  M Maximina Bertha Moreno-Altamirano; Israel Aguilar-Carmona; F Javier Sánchez-García
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

8.  Systemic immune system alterations in early stages of Alzheimer's disease.

Authors:  Rongzhen Zhang; Robert G Miller; Catherine Madison; Xia Jin; Ronald Honrada; Will Harris; Jonathan Katz; Dallas A Forshew; Michael S McGrath
Journal:  J Neuroimmunol       Date:  2013-02-04       Impact factor: 3.478

9.  HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.

Authors:  Eliseo A Eugenin; Gawain Dyer; Tina M Calderon; Joan W Berman
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

Review 10.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.